Macedonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

panic disorder/дебелина

Врската е зачувана во таблата со исечоци
Страница 1 од 48 резултати

Aryloxy piperidinyl derivatives for the treatment of depression

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
This invention relates to new aryloxy indole derivatives as pharmaceuticals which are useful for the treatment in mammals of diseases affected by disorders of the serotonin-affected neurological systems, such as depression, anxiety, panic disorder, obsessive-compulsive disorder, sleep disorders,

Indol carboxylic acid bispyridyl carboxamide derivatives, pharmaceutically acceptable salt thereof, preparation method and composition containing the same as an active ingredient

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
CROSS-REFERENCES TO RELATED APPLICATION This patent application claims the benefit of priority under 35 U.S.C. .sctn.119 from Korean Patent Application No. 10-2008-0033284 filed Apr. 10, 2008, the contents of which are incorporated herein by reference. TECHNICAL FIELD The present disclosure relates

Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
The present invention relates to cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives thereof, which are serotonin 5-hydroxytryptamine 2.sub.c (5HT.sub.2c) receptor agonists useful for the treatment of central nervous system disorders including, but not limited to, obsessive-compulsive

Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
The present invention relates to cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives thereof, which are serotonin 5-hydroxytryptamine 2.sub.C (5HT.sub.2C) receptor agonists useful for the treatment of central nervous system disorders including, but not limited to, obsessive-compulsive

Methods of modulating processes mediated by excitatory amino acid receptors

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
FIELD OF THE INVENTION The present invention relates to therapeutic methods for the treatment and prevention of various disease conditions using heterocyclic compounds. In addition, the invention relates to methods of modulating processes mediated by excitatory amino acid receptors. The invention

Heterocyclic carboxamides

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND OF THE INVENTION The present invention relates to novel heterocyclic carboxamides to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the present invention include selective agonists and antagonists of

Modulators of serotonin receptors

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND OF THE INVENTION The neurotransmitter/hormone serotonin (5-hydroxytryptamine, 5-HT) regulates many physiological processes via a group of at least 14 distinct receptors that are organized into 7 subfamilies (Hoyer, D., et al., Pharmacol. Rev., 46, 1994). The 5-HT.sub.2 subfamily is

Modulators of serotonin receptors

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND OF THE INVENTION The neurotransmitter/hormone serotonin (5-hydroxytryptamine, 5-HT) regulates many physiological processes via a group of at least 14 distinct receptors that are organized into 7 subfamilies (Hoyer, D., et al., Pharmacol. Rev., 46, 1994). The 5-HT.sub.2 subfamily is

Pyrrolo(oxo)quinolines as 5HT ligands

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND The neurotransmitter/hormone serotonin (5-hydroxytryptamine, 5-HT) regulates many physiological processes via a group of at least 14 distinct receptors that are organized into 7 subfamilies (Hoyer, D., et al., Pharmacol. Rev., 46, 1994). The 5-HT.sub.2 subfamily is composed of the

7-piperidinoalkyl-3, 4-Dihydroquinolone derivative

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
CROSS REFERENCE TO RELATED APPLICATIONS This is a National Stage of International Application No. PCT/JP2009/067441 filed Sep. 30, 2009, claiming priority based on Japanese Patent Application No. 2008-257072 filed Oct. 2, 2008, the contents of all of which are incorporated herein by reference in

Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
The present invention relates to the use of 1-[4-(5-cyanoindol-3-yl)butyl[-4-(2-carbamoyl-benzofuran-5-yl)-piperazine or a physiologically acceptable salt thereof, for the manufacture of a medicament for the treatment of sub-type anxiety

Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-pipe- razine and its physiologically acceptable salts

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
The present invention relates to the use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine or a physiologically acceptable salt thereof, for the manufacture of a medicament for the treatment of sub-type anxiety

Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-pipe- razine and its physiologically acceptable salts

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
The present invention relates to the use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine or a physiologically acceptable salt thereof, for the manufacture of a medicament for the treatment of sub-type anxiety

Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to inhibitors of the uptake of monoamine neurotransmitters and pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and the medical use of such compounds for the treatment

Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to inhibitors of the uptake of monoamine neurotransmitters and pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and the medical use of such compounds for the treatment
Придружете се на нашата
страница на Facebook

Најкомплетната база на податоци за лековити билки поддржана од науката

  • Работи на 55 јазици
  • Лекови од билки поддржани од науката
  • Препознавање на билки по слика
  • Интерактивна GPS мапа - означете ги билките на локацијата (наскоро)
  • Прочитајте научни публикации поврзани со вашето пребарување
  • Пребарувајте лековити билки според нивните ефекти
  • Организирајте ги вашите интереси и останете во тек со истражувањето на новостите, клиничките испитувања и патентите

Напишете симптом или болест и прочитајте за билки што можат да помогнат, напишете билка и видете болести и симптоми против кои се користи.
* Сите информации се базираат на објавени научни истражувања

Google Play badgeApp Store badge